Beijing Chunlizhengda Medical Instruments (01858) invests 50 million yuan in the healthcare industry fund.

Beijing Chunlizhengda Medical Instruments (01858) announced that the company, together with Nanchang DeFu Investment Consulting Partnership Enterprise (Limited Partnership) and other partners, has jointly invested in the Nanchang DeFu Phase IV Equity Investment Fund Partnership Enterprise (Limited Partnership). The investment focus of the partnership is mainly on companies/projects in the medical and health industry that are in the growth or mature stage and are relevant to the company's main business. The company, as a limited partner, has invested 50 million RMB of its own funds to subscribe for 9.2105% of the fund's shares. The announcement stated that this investment is in line with the company's strategic development direction and will benefit the company's industrial layout. By leveraging the investment experience and resource advantages of the partners, the company will promote the deep integration of industrial operations and capital operations, form a virtuous cycle of coordinated development, enhance the company's core competitiveness and overall profitability, and achieve sustained, secure, healthy, stable, and high-quality development.